These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Synthesis and structure-activity relationship study of pyrazolo[3,4-d]pyrimidines as tyrosine kinase RET inhibitors. Wang C; Liu H; Song Z; Ji Y; Xing L; Peng X; Wang X; Ai J; Geng M; Zhang A Bioorg Med Chem Lett; 2017 Jun; 27(11):2544-2548. PubMed ID: 28404375 [TBL] [Abstract][Full Text] [Related]
23. Inhibition of tumor cell growth, proliferation and migration by X-387, a novel active-site inhibitor of mTOR. Chen SM; Liu JL; Wang X; Liang C; Ding J; Meng LH Biochem Pharmacol; 2012 May; 83(9):1183-94. PubMed ID: 22305748 [TBL] [Abstract][Full Text] [Related]
24. Multisubstituted quinoxalines and pyrido[2,3-d]pyrimidines: synthesis and SAR study as tyrosine kinase c-Met inhibitors. Wu K; Ai J; Liu Q; Chen T; Zhao A; Peng X; Wang Y; Ji Y; Yao Q; Xu Y; Geng M; Zhang A Bioorg Med Chem Lett; 2012 Oct; 22(20):6368-72. PubMed ID: 22985853 [TBL] [Abstract][Full Text] [Related]
25. Synthesis, biological evaluation and docking studies of new pyrrolo[2,3-d] pyrimidine derivatives as Src family-selective tyrosine kinase inhibitors. Dincer S; Cetin KT; Onay-Besikci A; Ölgen S J Enzyme Inhib Med Chem; 2013 Oct; 28(5):1080-7. PubMed ID: 22957720 [TBL] [Abstract][Full Text] [Related]
26. Discovery of novel pyrazolo[1,5-a]pyrimidines as potent pan-Pim inhibitors by structure- and property-based drug design. Wang X; Magnuson S; Pastor R; Fan E; Hu H; Tsui V; Deng W; Murray J; Steffek M; Wallweber H; Moffat J; Drummond J; Chan G; Harstad E; Ebens AJ Bioorg Med Chem Lett; 2013 Jun; 23(11):3149-53. PubMed ID: 23623490 [TBL] [Abstract][Full Text] [Related]
27. Design, synthesis and preliminary biological evaluation of 4-aminopyrazole derivatives as novel and potent JAKs inhibitors. Liang X; Huang Y; Zang J; Gao Q; Wang B; Xu W; Zhang Y Bioorg Med Chem; 2016 Jun; 24(12):2660-72. PubMed ID: 27137359 [TBL] [Abstract][Full Text] [Related]
28. Akt Pathway Inhibitors. Uko NE; Güner OF; Matesic DF; Bowen JP Curr Top Med Chem; 2020; 20(10):883-900. PubMed ID: 32091335 [TBL] [Abstract][Full Text] [Related]
29. PH006, a novel and selective Src kinase inhibitor, suppresses human breast cancer growth and metastasis in vitro and in vivo. Ma JG; Huang H; Chen SM; Chen Y; Xin XL; Lin LP; Ding J; Liu H; Meng LH Breast Cancer Res Treat; 2011 Nov; 130(1):85-96. PubMed ID: 21181437 [TBL] [Abstract][Full Text] [Related]